Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2024-07-12

Clinical Trial Update: Huaiqihuang Granule in the Treatment of Primary Glomerulonephritis of Stage CKD3 [Phase 4]

View source ↗

Summary

This entry notes a Phase 4 clinical trial recruiting with Huaiqihuang Granule for primary glomerulonephritis in patients with chronic kidney disease stage 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Huaiqihuang Granule

Snippet

Sponsor: The First Affiliated Hospital of Dalian Medical University | Conditions: Renal Insufficiency, Chronic | Phase 4 | Status: RECRUITING